ASO Group’s Bristol-Myers Squibb BMY Stock Holding History

ASO Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$871K	Hold	15,116	–	–	0.37%	37
2026 Q1	$917K	Hold	15,116	–	–	0.39%	35
2025 Q4	$815K	Buy	+15,116	New	+$727K	0.32%	38

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ASO Group's BMY Position: Q2 2026 in Review

ASO Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 15,116 shares worth $871K. The position accounts for 0.37% of the portfolio, ranked #37.

ASO Group first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $917K in Q1 2026. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

ASO Group held 15,116 shares of Bristol-Myers Squibb worth $871K as of Q2 2026.
ASO Group left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.37% of ASO Group's portfolio in Q2 2026, its #37 holding.
ASO Group first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
ASO Group's Bristol-Myers Squibb position peaked at $917K in Q1 2026.
2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on ASO Group's 13F filing for Q2 2026, filed 4 Aug 2026.